Close

Syros Pharmaceuticals (SYRS) Releases Foundational Data Supporting Ongoing Phase 2 Clinical Trial of SY-1425 for Genomically Defined AML & MDS Patients Jul 21, 2017 08:05AM
Syros Pharmaceuticals (SYRS) Names Srinivas Akkaraju to Board Jun 12, 2017 10:13AM